Rani Therapeutics Holdings (RANI) Payables (2020 - 2026)
Rani Therapeutics Holdings' (RANI) quarterly Payables came in at $858000.0 in Q1 2026, down 43.55% year-on-year from $1.5 million in Q1 2025, and up 177.67% quarter-over-quarter from $309000.0 in Q4 2025.
Rani Therapeutics Holdings (RANI) Payables (2020 - 2026) Analysis & Trends
Rani Therapeutics Holdings' Payables history runs 7 years deep, the most recent figure standing at $858000.0 for Q1 2026.
- On a quarterly basis, Payables fell 43.55% year-over-year to $858000.0 in Q1 2026; TTM through Mar 2026 was $858000.0, a 43.55% decrease from a year earlier, with the FY2025 full-year figure at $309000.0, down 77.26% from the prior year.
- Payables rose to $858000.0 in Q1 2026 per RANI's latest filing, from $309000.0 in the prior quarter.
- Across five years, Payables topped out at $2.5 million in Q3 2025 and bottomed at $309000.0 in Q4 2025.
- The 5-year median for Payables is $1.4 million (2023), against an average of $1.3 million.
- Biggest YoY gain for Payables was 255.34% in 2025; the steepest drop was 77.26% in 2025.
- Year by year, Payables stood at $1.5 million in 2022, then slumped by 55.62% to $648000.0 in 2023, then soared by 109.72% to $1.4 million in 2024, then slumped by 77.26% to $309000.0 in 2025, then soared by 177.67% to $858000.0 in 2026.
- Per Business Quant, the three latest RANI Payables figures stand at $858000.0 (Q1 2026), $309000.0 (Q4 2025), and $2.5 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Rani Therapeutics Holdings | 160.20 Mn | 167.33 Mn | - | 858,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 858,000.00 |
| Dec 31, 2025 | 309,000.00 |
| Sep 30, 2025 | 2.47 Mn |
| Jun 30, 2025 | 1.80 Mn |
| Mar 31, 2025 | 1.52 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 506,000.00 |
| Mar 31, 2024 | 806,000.00 |
| Dec 31, 2023 | 648,000.00 |
| Sep 30, 2023 | 1.41 Mn |
| Jun 30, 2023 | 1.04 Mn |
| Mar 31, 2023 | 1.51 Mn |
| Dec 31, 2022 | 1.46 Mn |
| Sep 30, 2022 | 1.79 Mn |
| Jun 30, 2022 | 1.44 Mn |
| Mar 31, 2022 | 1.27 Mn |
| Dec 31, 2021 | 1.08 Mn |
| Sep 30, 2021 | 1.31 Mn |
| Jun 30, 2021 | 1.67 Mn |